Lipopolysaccharide alters nucleotidase activities from lymphocytes and serum of rats

Life Sciences

Volumn 80, Issue 19, 2007, Pages 1784-1791

  Vuaden, Fernanda Cenci ^a   de Paula Cognato, Giana ^a   Bonorino, Cristina ^b   Bogo, Maurício Reis ^b   de Freitas Sarkis, João José ^a   Bonan, Carla Denise ^b  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

5 nucleotidase; Adenosine; ATP; Endotoxemia; LPS; NPP; NTPDase

Indexed keywords

ECTO 5' NUCLEOTIDASE; LIPOPOLYSACCHARIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ENDOTOXEMIA; ENZYME ACTIVITY; IN VITRO STUDY; IN VIVO STUDY; LIPID HYDROLYSIS; LYMPHOCYTE; MALE; MESENTERY LYMPH NODE; NONHUMAN; NUCLEOTIDE METABOLISM; PROTEIN EXPRESSION; RAT; SERUM;

ADENINE NUCLEOTIDES; ANIMALS; APYRASE; DISEASE MODELS, ANIMAL; ENDOTOXEMIA; ESCHERICHIA COLI; GENE EXPRESSION; HYDROLYSIS; LIPOPOLYSACCHARIDES; LYMPHOCYTES; MALE; NUCLEOTIDASES; RATS; RATS, WISTAR;

RATTUS;

EID: 34147150060     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2007.02.015     Document Type: Article

References (54)

1. Airas L. CD73 and adhesion of B-cells to follicular dendritic cells. Leukemia & Lymphoma 29 1-2 (1998) 37-47
2. Baricordi O.R., Melchiorri L., Adinolfi E., Falzoni S., Chiozzi P., Buell G., and Di Virgilio F. Increased proliferation rate of lymphoid cells transfected with the P2X(7) ATP receptor. The Journal of Biological Chemistry 274 (1999) 33206-33208
3. Bigonnesse F., Levesque S.A., Kukulski F., Lecka J., Robson S.C., Fernandes M.J., and Sevigny J. Cloning and characterization of mouse nucleoside triphosphate diphosphohydrolase-8. Biochemistry 43 18 (2004) 5511-5519
4. Bodin P., and Burnstock G. Increased release of ATP from endothelial cells during acute inflammation. Inflammation Research 47 8 (1998) 351-354
5. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry 72 (1976) 248-256
6. Burnstock G. Introduction: P2 receptors. Current Topics in Medicinal Chemistry 4 (2004) 793-803
7. Buvinic S., Briones R., and Huidobro-Toro J.P. P2Y(1) and P2Y(2) receptors are coupled to the NO/cGMP pathway to vasodilate the rat arterial mesenteric bed. Brithish Journal of Pharmacology 136 (2002) 847-856
8. Capecchi P.L., Camurri A., Pompella G., Mazzola A., Maccherini M., Diciolla F., Lazzerini P.E., Abbracchio M.P., and Laghi-Pasini F. Upregulation of A2A adenosine receptor expression by TNF-α in PBMC of patients with CHF: a regulatory mechanism of inflammation. Journal of Cardiac Failure 11 1 (2005) 67-73
9. 2+-stimulated ATPase activity. Analytical Biochemistry 157 (1986) 375-380
10. Cunha R.A. Regulation of the ecto-nucleotidase pathway in rat hippocampal nerve terminals. Neurochemistry Research 26 8-9 (2001) 979-991
11. Di Virgilio F., Chiozzi P., Ferrari D., Falzoni S., Sanz J.M., Morelli A., Torboli M., Bolognesi G., and Baricordi O.R. Nucleotide receptors: an emerging family of regulatory molecules in blood cells. Blood 97 (2001) 587-600
12. Dombrowski K.E., Ke Y., Thompson L.F., and Kapp J.A. Antigen recognition by CTL is dependent upon ectoATPase activity. Journal of Immunology 154 12 (1995) 6227-6237
13. Dombrowski K.E., Ke Y., Brewer K.A., and Kapp J.A. Ecto-ATPase: an activation marker necessary for effector cell function. Immunological Reviews 161 (1998) 111-118 (Review)
14. Enjyoji K., Sevigny J., Lin Y., Frenette P.S., Christie P.D., Esch II J.S., Imai M., Edelberg J.M., Rayburn H., Lech M., et al. Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation. Nature Medicine 5 (1999) 1010-1017
15. Ferrari D., Chiozzi P., Falzoni S., Hanau S., and Di Virgilio F. Purinergic modulation of interleukin-1 beta release from microglial cells stimulated with bacterial endotoxin. The Journal of Experimental Medicine 185 (1997) 579-582
16. Ferrari D., La Sala A., Chiozzi P., Morelli A., Falzoni S., Girolomoni G., Idzko M., Dichmann S., Norgauer J., and Di Virgilio F. The P2 purinergic receptors of human dendritic cells: identification and coupling to cytokine release. The FASEB Journal 14 (2000) 2466-2476
17. Fillippini A., Taffs R.E., Agui T., and Sitkovsky M.V. Ecto-ATPase activity in citolytic T-lymphocytes, protection of the cytolytic effects of extracellular ATP. The Journal of Biological Chemistry 265 (1990) 334-340
18. Fredholm B.B., Ijzerman A.P., Jacobson K.A., Klotz K.N., and Linden J. International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacological Reviews 53 (2001) 527-552
19. Goding J.W., Grobben B., and Slegers H. Physiological and pathophysiological functions of the ecto-nucleotide pyrophosphatase/phosphodiesterase family. Biochimica et Biophysica Acta 1638 (2003) 1-19
20. Goepfert C., Imai M., Brouard S., Csizmadia E., Kaczmarek E., and Robson S.C. CD39 modulates endothelial cell activation and apoptosis. Molecular Medicine 6 (2000) 591-603
21. Goepfert C., Sundberg C., Sevigny J., Enjyoji K., Hoshi T., Csizmadia E., and Robson S. Disordered cellular migration and angiogenesis in cd39-null mice. Circulation 104 (2001) 3109-3115
22. Harada H., Chan C.M., Loesch A., Unwin R., and Burnstock G. Induction of proliferation and apoptotic cell death via P2Y and P2X receptors, respectively, in rat glomerular mesangial cells. Kidney International 57 (2000) 949-958
23. Haskó G., Szabo C., Nemeth Z.H., Kvetan V., Pastores S.M., and Vizi E.S. Adenosine receptor agonists differentially regulate IL-10, TNF-α and nitric oxide production in RAW 264.7 macrophages and in endotoxemic mice. Journal of Immunology 157 (1996) 4634-4640
24. 2A receptor-dependent and independent mechanisms. The FASEB Journal 14 (2000) 2065-2074
25. Haskó G., and Cronstein B.N. Adenosine: an endogenous regulator of innate immunity. Trends in Immunology 25 (2004) 33-39
26. Hogan C.J., Fang G.D., Scheld W.M., Linden J., and Diduch D.R. Inhibiting the inflammatory response of joint sepsis. Arthroscopy 17 (2001) 311-315
27. Hu Y., Fisette P.L., Denlinger L.C., Guadarrama A.G., Sommer J.A., Proctor R.A., and Bertics P.J. Purinergic receptor modulation of lipopolysaccharide signaling and inducible nitric-oxide synthase expression in RAW 264.7 macrophages. The Journal of Biological Chemistry 273 (1998) 27170-27175
28. Imai M., Goepfert C., Kaczmarek E., and Robson S.C. CD39 modulates IL-1 release from activated endothelial cells. Biochemical and Biophysical Research Communications 270 (2000) 272-278
29. Jabs C.M., Sigurdsson G.H., and Neglen P. Plasma levels of high-energy compounds compared with severity of illness in critically ill patients in intensive care unit. Surgery 124 (1998) 65-72
30. Krishna S., Andersson A.M., Semsey S., and Sneppen K. Structure and function of negative feedback loops at the interface of genetic and metabolic networks. Nucleic Acids Research 34 8 (2006) 2455-2462
31. Maliszewski C.R., Delespesse G.J., Schoenborn M.A., Armitage R.J., Fanslow W.C., Nakajima T., Baker E., Sutherland G.R., Poindexter K., and Birks C. The CD39 lymphoid cell activation antigen. Molecular cloning and structural characterization. Journal of Immunology 153 (1994) 3574-3583
32. Marrelli S.P. Mechanisms of endothelial P2Y(1)- and P2Y(2)-mediated vasodilatation involve differential [Ca2+] responses. American Journal of Physiology. Heart and Circulatory Physiology 281 (2001) H1759-H1766
33. Martin C., Leone M., Viviand X., Ayem M.L., and Guieu R. High adenosine plasma concentration as a prognostic index for outcome in patients with septic shock. Critical Care Medicine 28 9 (2000) 3198-3202
34. McCloskey M.A., Fan Y., and Luther S. Chemotaxis of rat mast cells toward adenine nucleotides. Journal of Immunology 163 (1999) 970-977
35. Molloy A., Laochumroonvorapong P., and Kaplan G. Apoptosis, but not necrosis, of infected monocytes is coupled with killing of intracellular bacillus Calmette-Guerin. The Journal of Experimental Medicine 180 (1994) 1499-1509
36. Oses J.P., Cardoso C.M., Germano R.A., Kirst I.B., Rücker B., Fürstenau C.R., Wink M.R., Bonan C.D., Battastini A.M.O., and Sarkis J.J.F. Soluble NTPDase: An additional system of nucleotide hydrolysis in rat blood serum. Life Sciences 74 (2004) 3275-3284
37. Quinlan G.J., Lamb N.J., Tilley R., Evans T.W., and Gutteridge J.M. Plasma hypoxanthine levels in ARDS: implications for oxidative stress, morbidity and mortality. American Journal of Respiratory and Critical Care Medicine 155 (1997) 479-484
38. Ralevic V., and Burnstock G. Receptors for purines and pyrimidines. Pharmacological Reviews 50 (1998) 413-492
39. Resta R., Yamashita Y., and Thompson L.F. Ecto-enzyme and signaling functions of lymphocyte CD73. Immunological Reviews 161 (1998) 95-109
40. Rodriguez-Nunez A., Cid E., Rodriguez-Garcia J., Camina F., Rodriguez-Segade S., and Castro-Gado M. Concentrations of nucleotides, nucleosides, purine bases, oxypurines, uric acid and neuron-specific enolase in the cerebrospinal fluid of children with sepsis. Journal of Child Neurology 16 (2001) 704-706
41. Sakura H., Nagashima S., Nakashima A., and Maeda M. Characterization of fetal serum 5'nucleotide phosphodiesterase: a novel function as a platelet aggregation inhibitor in fetal circulation. Thrombosis Research 91 (1998) 83-89
42. Schulte am Esch II J., Sevigny J., Kaczmarek E., Siegel J.B., Imai M., Koziak K., Beaudoin A.R., and Robson S.C. Structural elements and limited proteolysis of CD39 influence ATP diphosphohydrolase activity. Biochemistry 38 (1999) 2248-2258
43. Sitkovsky M.V., Lukashev D., Apasov S., Kojima H., Koshiba M., Caldwell C., Ohta A., and Thiel M. Physiological control of immune response and inflammatory tissue damage by hypoxia-inducible factors and adenosine A2A receptors. Annual Review of Immunology 22 (2004) 657-682
44. Solle M., Labasi J., Perregaux D.G., Stam E., Petrushova N., Koller B.H., Griffiths R.J., and Gabel C.A. Altered cytokine production in mice lacking P2X(7) receptors. The Journal of Biological Chemistry 276 (2001) 125-132
45. Spolarics Z., Stein D.S., and Garcia Z.C. Endotoxin stimulates hydrogen peroxide detoxifying activity in rat hepatic endothelial cells. Hepatology 24 (1996) 691-696
46. 2A adenosine receptors inhibits inflammation in a rat model of meningitis: synergy with the type IV phosphodiesterase inhibitor, rolipram. The Journal of Infectious Diseases 180 (1999) 1550-1560
47. 2A receptor agonists as anti-inflammatory agents. Current Opinion in Investigational Drugs 4 11 (2003) 1313-1319
48. Sullivan G.W., Fang G., Linden J., and Scheld W.M. Adenosine receptor activation improves survival in mouse of endotoxemia and sepsis. The Journal of Infectious Diseases 189 (2004) 1897-1904
49. 2A receptors in downregulation of inflammation and immunity in the pathogenesis of infectious diseases. Microbes and Infection 5 6 (2003) 515-526
50. von Albertini M., Palmetshofer A., Kaczmarek E., Koziak K., Stroka D., Grey S.T., Stuhlmeier K.M., and Robson S.C. Extracellular ATP and ADP activate transcription factor NF-kappa B and induce endothelial cell apoptosis. Biochemical and Biophysical Research Communications 248 (1998) 822-829
51. Vorhoff T., Zimmermann H., Pelletier J., Sévigny J., and Braun N. Cloning and characterization of the ecto-nucleotidase NTPDase3 from rat brain: predicted secondary structure and relation to other members of E-NTPDase family and actin. Purinergic Signalling 1 (2005) 259-270
52. Wu G., Field C.J., and Marliss E.B. Glutamine and glucose metabolism in rat splenocytes and mesenteric lymph node lymphocytes. The American Journal of Physiology 260 23 (1991) 141-147
53. Yegutkin G.G. Kinectic analysis of enzymatic hydrolysis of ATP in human and rat blood serum. Biochemistry (Moscow) 62 (1997) 724-728
54. Zimmermann H. Ectonucleotidases: some recent developments and note on nomenclature. Drug Development Research 52 (2001) 46-56